e-Stroke Featured in The Guardian's "Future of Healthcare" Supplement

The article highlights the impact of e-Stroke on a network, enabling faster detection of stroke to allow more patients acces to thrombectomy, resulting in the prevention of stroke-related disability and death.

Brainomix Partners with TIPAL Trial to Assess Its Novel IPF Biomarker in Lung Disease

The company will apply its cutting-edge AI technology to run a sub-study assessing the value of its novel imaging biomarkers

Brainomix Software Used in Post-Hoc Assessment of Acticor Biotech's ACTIMIS Study Results

The results generated by Brainomix's core lab analysis with its AI software reinforced glenzocimab's mode of action in stroke patients

Brainomix AI Technology Improves Access to Life-Changing Stroke Treatments

Sites with e-Stroke are delivering higher thrombectomy rates for stroke patients in a faster time, according to a recent report from the Oxford Academic Health Science Network

Brainomix Takes Two Top Prizes at Thames Valley Tech Awards

Brainomix was awarded Innovative Tech Company of the Year as well as Life Sciences & Health Tech Company of the Year.

Brainomix Showcased by Department of Health as Part of the New AI Fund

Brainomix's e-Stroke technology featured in the Department of Health's recent showcase of “most promising AI imaging and decision support tools” as part of the roll-out of the £21M AI Diagnostic Fund.

New Data Presented at American Thoracic Society Showcases the Value of Brainomix e-Lung Software

Brainomix’s e-Lung software is powered by unique imaging biomarkers that have demonstrated superior prognostic value compared with traditional measures in both non-IPF and IPF ILD patients.

Brainomix Expands its UK Headquarters with New Facilities in Oxford

We've relocated to the landmark Seacourt Tower in Botley

Brainomix moves UK headquarters & opens in US

Oxford & Chicago facilities to accommodate growing team of specialists at company focused on treatments for stroke, lung fibrosis and cancer

Brainomix expands UK HQ with new Oxford facilities

Oxford-based AI-powered medtech solutions company Brainomix has announced its move to a new head office at the Seacourt Tower in Botley.

Brainomix expands U.K. headquarters

Artificial intelligence (AI) software developer Brainomix has expanded into new headquarters in Oxford, U.K.

Brainomix Nominated for Prestigious Prix Galien Award

The e-Stroke platform was nominated in the category of "Best Digital Health Solution," recognizing its transformative impact stroke care.

Brainomix Joins CEO Roundtable on Cancer as Newest Member

The Oxford-based company is the first AI imaging company to join the organization

Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software

Our stroke AI solutions are now poised to take its transformative technology to US stroke centers

Stroke & AI: How the e-Stroke software is reducing door in door out time for stroke patients

National Consortium of Intelligent Medical Imaging video explaining how our e-Stroke software is reducing door in door out time for stroke patients

Brainomix Technology Integrated into New UK Atrial Fibrillation Study

The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients

UK atrial fibrillation research incorporates Brainomix

Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients

Brainomix AI used in UK atrial fibrillation study

This major study will look at how effective a wearable device and Brainomix AI software are in the detection of atrial fibrillation

Blackford and Brainomix Announce AI Partnership for Stroke Care

Strategic partnership increases access to advanced AI-assisted stroke care

AI-led system improving stroke treatment and outcomes

Brainomix e-Stroke system supporting cut in waiting times and reducing disability

Risk-averse NHS should stop more strokes with AI technology

Prof Kevin Moore advocates for the wider adoption of e-Stroke as a way of improving outcomes for stroke patients.

Rising stars: three fast-growing health and life sciences companies

Brainomix featured as part of a 'Rising Stars' piece on fast-growing UK health and life sciences companies, with an interview with CEO and Co-Founder Michalis Papadakis.

AI technology triples stroke recovery

Brainomix featured in The Times, highlighting the impact that the e-Stroke platform has had on stroke care in the NHS.

Artificial intelligence revolutionising NHS stroke care

Use of cutting-edge AI technology is associated with a tripling of the number of patients recovering and able to perform daily activities from 16% to 48%.

Brainomix announces new partnership with Pixyl to expand its offering with multiple sclerosis solution

Brainomix to distribute Pixyl.Neuro.MS Software as a Service (SaaS) solution exclusively in the UK and Ireland, the Nordics and key Eastern Europe markets

Brainomix, Visionable partner to boost care delivery for stroke patients

Visionable’s digital healthcare collaboration platform, used with Brainomix’s e-Stroke software, will allow more stroke patients to get appropriate treatment.

Visionable and Brainomix announce strategic partnership to tackle “bottlenecks” in time-sensitive stroke care pathway

Benefits of combining Visionable’s virtual platform with Brainomix’s e-Stroke imaging already demonstrated at Ipswich Hospital

UK digital health firms join together on stroke care platform

A partnership between two UK digital health companies – Brainomix and Visionable – aims to overcome stroke care bottlenecks.

Brainomix and Visionable announce AI partnership

Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK.

Strategic partnership tackles bottlenecks in stroke pathway

Visionable and Brainomix use AI-powered solutions to address time-sensitive stroke care.

Brainomix Announces Collaboration with UK Government-Funded NCIMI to Evaluate AI-Powered Technology in Lung Cancer Care

Study to evaluate e-ACT for automated assessment of disease progression and treatment response for lung cancer

Brainomix and Bridge Biotherapeutics, Inc. Announce Partnership to Utilize Brainomix’ AI-Powered e-ILD Software for Automated Assessment of Idiopathic Pulmonary Fibrosis (IPF)

The partnership will focus on quantitative analysis of imaging data by Brainomix's e-ILD software within the Phase 2 Study of BBT-877 in IPF

Brainomix's AI Software to be Rolled Out Across Hungary’s Entire National Healthcare System to Improve Stroke Care

Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care.

Brainomix & OSIC: A Pioneering Partnership Driving Innovation in Interstitial Lung Disease (ILD)

Brainomix and OSIC present new data showcasing the value of its new e-ILD platform, centered around a novel, AI-powered imaging biomarker that has demonstrated superior prognostic value.

Brainomix awarded tender to deploy AI stroke imaging across whole of Hungary

AI stroke imaging will be deployed across centers in Hungary after Brainomix was awarded a national tender.

Hungary will deploy Brainomix AI stroke software nationwide

Brainomix claims first national contract – from Hungary – for its AI platform for improved diagnosis and treatment of stroke.

e-Stroke Goes Live Across the Gothenburg Region

Brainomix software deployed to 10 stroke centers across the region after winning a highly competitive, multi-year EU tender process.

Brainomix Expands Leadership Team with Appointment of Melissa Strange as Chief Financial Officer and Jérôme Galbrun as Chief Revenue Officer

New CFO and CRO appointed with overall resources more than doubling following last December’s £16M financing round

e-Stroke Helps Lecce Stroke Team Deliver an Expanded and Expedient Thrombectomy Service

Lecce have seen their thrombectomy service double in two years, on target to achieve more than 140 procedures in 2022.

Creating an Exemplary Stroke Unit in the Center of Athens

Euroclinic invests in artificial intelligence, setting the bar higher in the handling and treatment of patients with stroke.

Brainomix Announces the Development of a Proprietary AI-Trained Predictive Biomarker for Idiopathic Pulmonary Fibrosis (IPF)

The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical trials

Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-Powered Radiomic Software for Automated Assessment of Solid Tumor Cancer

The collaboration will focus on the development of AI tools to improve the accuracy and standardization of tumor measurement in lung cancer trials

Brainomix Launches e-Stroke 11 to Enhance Stroke Network Communications and Workflow

The latest advancement will extend the e-Stroke platform to enable messaging and image-sharing across stroke networks, helping to optimize workflow and facilitate faster treatment

Brainomix Closes £16M ($21.2M) Financing Round to Expand Its Proven AI-Enabled Platform Beyond Stroke

The Series B investment will enable the Oxford-based company to expand its award-winning artificial intelligence (AI) portfolio into new indications and extend into new high-growth markets

Brainomix & Barts NHS Trust Partner to Transform Stroke Care

Barts NHS Trust provides a 24/7 thrombectomy service, and is on pace to treat more than 300 patients this year with this life-saving procedure

Brainomix’s AI Stroke Software Goes Live Across Poland

Brainomix were awarded the first national tender in Europe to deploy its AI stroke software as part of the Polish Ministry of Health initiative to improve stroke care

Dartford and Gravesham NHS Trust Deploy e-Stroke Across Their Network

The AI-powered software has been a real game changer, helping the Trust make faster treatment and transfer decisions for its stroke patients

e-Stroke Goes Live Across the East Sussex Healthcare Trust

The roll-out of e-Stroke across Sussex is aimed at expanding access to fast, effective, lifesaving treatment for all stroke patients.

BBC News Focuses on Brainomix Software

The segment showcases how Brainomix's e-Stroke software is helping the Royal Berkshire Hospital stroke team deliver best-in-class care.

Brainomix Featured in The New Statesman: "How AI Is Speeding Up Stroke Care"

Saving time in delivering thrombectomy services could be the difference between a good outcome and someone facing a life with a serious disability.

Brainomix’s e-Stroke Software Goes Live Across the University Hospitals Sussex NHS Foundation Trust

This latest deployment of Brainomix’s transformative stroke AI imaging platform will support the Trust’s focus on delivering innovative care for its patients

Brainomix’s e-Stroke Platform Goes Live at North Tees & Hartlepool NHS Foundation Trust

Brainomix continues to be a strong partner of NHS stroke teams, with this latest deployment part of a wider North East of England stroke AI network

Brainomix's e-Stroke Featured in The Times

Article highlights the value of e-Stroke in helping physicians identify stroke and optimize treatment

e-Stroke Helps Lübeck Stroke Team Optimize Their Stroke Service

The stroke team at Sana Kliniken Lübeck share their experience with e-Stroke over the past 12 months

Brainomix Selected to Present at Premier Tech Investor Events

Recognized as one of the most innovative companies in Europe, Brainomix is attracting the attention of leading tech investors

Brainomix Announces New Partnership with Stryker Neurovascular to Expand Access to Life-Saving Stroke Treatments

The partnership will enable both companies to work towards improving care across stroke networks

New Study Strengthens the Value of e-ASPECTS and Simple Imaging in Stroke Treatment Decision Making

Results will enable stroke networks to make more confident treatment decisions in both specialist and non-specialist stroke hospitals

A Year-End Reflection on 2020

2020 was marked by a global pandemic – but also saw significant progress and innovation

Brainomix Announced as Founder Member of Open Source Imaging Consortium (OSIC)

Joins renowned global organization connecting academia, industry and philanthropy in the fight against lung disease

Join US at the ESO-WSO 2020 Virtual Conference

Brainomix software to be featured in a number of scientific presentations and posters

Brainomix Joins the Endeavor Scale-Up Program

Joins global network of fast-growing, innovative companies founded by Greek entrepreneurs.

Introducing the New Brainomix Identity

We'd like to introduce you to the new Brainomix identity, which reflects our company's world-class expertise and focus on delivering cutting-edge AI solutions for better treatment decisions.

Brainomix Featured in Financial Times

Announcement of New Chairperson and Expanded Board Featured in FT

Brainomix Announces Appointment of New Chairperson and Expanded Board

The Oxford-based company at the forefront of medical AI imaging welcomes new Board members with pharmaceutical and imaging expertise

Brainomix Achieves Breakthrough in Stroke Imaging with New Software Release

e-Stroke Suite 10.0 provides first-ever clot detection from non-contrast CT scans, a paradigm shift

AI Software Developers Win Big in U.K. Initiative

Brainomix awarded NHSX grant for AI software

Brainomix Awarded Prestigious AI Grant to Demonstrate Impact in NHS

Company selected to participate in groundbreaking NHS AI initiative

University Hospital Milton Keynes adopts AI

University Hospital Milton Keynes NHS FT has adopted AI technology from Brainomix into its Stroke Practice

University Hospital Milton Keynes Incorporates e-Stroke Suite into their Stroke Practice

AI is now helping clinicians at Milton Keynes deliver quicker and safer care to stroke patients

e-Stroke Suite Featured in Royal College of Physicians' Podcast

Dr Kiruba Nagaratnam discusses changes to the thrombectomy pathway and assesment during COVID-19

Brainomix Software Featured in Sky News Segment

e-Stroke Suite was showcased as part of a Sky News segment on how AI solutions are helping stroke teams

Expansion of e-Stroke Suite Across Thames Valley Continues with Deployment at Buckinghamshire Healthcare NHS Trust

Trust becomes latest hospital in region to adopt software for Thames Valley Stroke Network

A Mid-Year Update from Brainomix

An update on some of the exciting developments from the first half of 2020

e-Stroke Suite Goes Live at Newcastle Upon Tyne Hospitals Trust

Deployment of e-Stroke software across the UK continues with Northeast region

AI Technology Developed in Oxford Speeds Up Stroke Care and Reduces Cost

Clinicians are making swift, accurate decisions around stroke care thanks to AI-enabled imaging software

New e-Stroke Mobile App: Enabling Fast, Remote Access to Key Results

Brainomix's new e-Stroke Mobile App provides landmark capabilities for stroke networks

e-Stroke Mobile App Helps Royal Berkshire Stroke Team Manage Service During COVID-19 Crisis

Stroke team using e-Stroke Mobile app to maintain optimal stroke care during pandemic

Sana Klinik Lübeck Incorporates e-Stroke Suite Into Stroke Service

New software promises to improve stroke service in Lübeck

Brainomix AI Software Featured in The Daily Mail

Article focused on the role of AI solutions in healthcare

Royal Berkshire Hospital Becomes The First To Use AI Software To Diagnose Strokes

e-Stroke Suite has been deployed at Royal Berks

e-Stroke Suite Launched Across Slovakian Stroke Network

Brainomix software will help stroke network optimize its service

Slovakian News Showcases Brainomix Software as Part of Regional Stroke Network Deployment

e-Stroke Suite is being rolled out across one of the largest stroke networks in Slovakia

Brainomix Announces the Launch of its New e-Stroke Suite 9.0

The latest software includes the new e-Stroke Cloud Service to facilitate faster sharing of results across a stroke network

Brainomix Included in Prestigious Group of "Global Digital Health 100" Companies

Awards recognize companies with greatest potential to change the way healthcare is delivered

Six Industry Experts Share their Vision for Healthcare IT in 2020

Brainomix CEO and Co-Founder, Dr Michalis Papadakis, discusses the role of AI in healthcare

UK Clinical Network Launches Pioneering AI Stroke Project

The collaboration will enable Trusts in the network to introduce intelligent AI algorithms into existing radiology workflows

Brainomix AI software improves stroke treatment rates at Budapest University Hospital

Results showed that treatment rates for stroke patients improved and treatment times were reduced following the installation of Brainomix’s e-Stroke Suite

New Results: Brainomix Software Shown to Improve Stroke Treatment Rates at Budapest University Hospital

e-Stroke Suite increased thrombolysis and thrombectomy treatment rates for stroke patients

Brainomix Joins Global Stroke Community to Mark World Stroke Day 2019

Brainomix committed to working with clinicians to make life-saving treatments accessible to all stroke patients

New Study: Using Simple Brain Scans Brainomix AI Software Can Generate Critical Information for the Treatment of Stroke Patients

New study shows Brainomix’s unique AI-driven software gives doctors reliable information to treat stroke patients from universally available imaging systems

Brainomix Featured in BBC Technology Segment Focused on AI in Healthcare

Brainomix were recently featured in a BBC News Technology segment focused on AI in healthcare

Brainomix Participates in NHS Expo with Boehringer Ingelheim to Showcase Transformative AI Portfolio for Stroke

Event focused on NHS Long Term Plan and the role of AI solutions

Brainomix Software Used to Select Patients in Ground-Breaking Brazilian Stroke Trial

First trial to demonstrate efficacy of thrombectomy in developing world healthcare system

Brainomix Software Transforms Stroke Care in Braunschweig

Brainomix’s e-Stroke Suite was recently featured in an article published by Klinikum Braunschweig

New Study: Brainomix Stroke Imaging Solution Improves Consistency of Image Interpretation for Doctors

New study shows Brainomix e-CTA provides similar measures to experts and improves inter-rater reliability

Brainomix to Attend European Stroke Organisation Conference (ESOC) 2019 in Milan

Brainomix invites you to join us at ESOC 2019 to experience first-hand the most comprehensive imaging solution

New ESO Guidelines on Mechanical Thrombectomy

Guidelines reinforce the importance of imaging in determining patient eligibility

Brainomix & Angels Initiative Releases the Angels WOW CT Training Tool

e-ASPECTS software supports physicians’ diagnostic skills by delivering fast and consistent stroke diagnosis

New Study Highlights Clinical Value of Brainomix's e-ASPECTS Software for Stroke Patients

Ischemic injury on e-ASPECTS, but not RAPID software, predicted good clinical outcome at 3 months after stroke

Brainomix Listed as Finalist for “Best New Radiology Software” for Its e-CTA Stroke Imaging Solution

Awards recognize excellence in European Radiology

Study Shows e-ASPECTS May Be Sufficient for Selection of Late-Time Window Thrombectomy Patients

Study suggests it may be reasonable to select patients for thrombectomy in centres without access to advanced imaging using the e-ASPECTS tool in combination with clinical criteria

Angels Initiative Wins Prestigious 2018 EFPIA Health Collaboration Award for Improving Stroke Care

Brainomix is the sole imaging partner for the community of more than 1,000 hospitals enrolled in the Angels Initiative

Brainomix Partners with Oxford University in UK Government-Funded £17.5 Million Artificial Intelligence Programme

Stroke imaging software, e-Stroke Suite, to demonstrate life-saving impact of AI-based technologies

New Study: e-ASPECTS Predicts Patient Outcome and Risk of Bleeding in Acute Stroke

New publication in Stroke journal with 1,500 patients from the ENCHANTED trial database

Brainomix & Olea Medical Join Forces to Revolutionize Stroke Imaging

The new e-Stroke Suite is the complete decision support software for the assessment of CT and MR scans of ischemic stroke patients

Brainomix Announces CE Mark Certification for New e-CTA Software

e-CTA provides fast, automated collateral assessments powered by AI and big data

Brainomix Secures £7m ($9.8m) Investment to Tackle Stroke with AI

Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims

Brainomix Announces New Software Release e-ASPECTS 7.0

New version of Brainomix’s flagship product, e-ASPECTS, offers exciting new features and improvements

Brainomix at WFITN 2017 Budapest

Brainomix will be exhibiting at the 14th Congress of the World Federation of Interventional and Therapeutic Neuroradiology

e-ASPECTS in Thrombectomy Trial in Brazil

The only mechanical thrombectomy trial in a developing country is currently taking place in Brazil

American Journal of Neuroradiology Publication

A new study shows e-ASPECTS correlates with and is a predictor of outcome

Brainomix Featured in Oxford Mail

" Summertown firm's Brainy idea will help stroke victims across Europe..."

Brainomix at ESOC 2017

Brainomix will be participating at the 3rd European Stroke Conference (ESOC 2017)

Brainomix Announces Partnership with Boehringer Ingelheim's Angels Initiative

Partnership will enable both companies to help improve stroke care across the region

Brainomix at ANIM 2017

Brainomix will be attending the Annual Meeting of the German & Austrian Stroke Society

Brainomix Announces Latest Release of its e-ASPECTS software

The new software version of Brainomix’s flagship product offers exciting new features and improvements

International Journal of Stroke Publication

Results show e-ASPECTS is on average statistically non-inferior to expert neuroradiologists

Brainomix Completes a £1.5 Million Investment Round

Funding will enable Brainomix to further commercialize its proprietary software

Brainomix at neuroRAD 2016 Conference

Will be attending the neuroradiology event in Cologne

Brainomix Releases CT Imaging Resource Guide

Guide provides an overview of CT scanning techniques and their clinical application in ischemic stroke

Journal of Cerebrovascular Diseases Publication

Study illustrates the potential benefits of e-ASPECTS when integrated within Mobile Stroke Units

Brainomix at ESOC 2016

Brainomix is attending the 2016 European Stroke Organization Conference in Barcelona

International Journal of Stroke Publication

Study shows e-ASPECTS performs as well as stroke experts when assessing brain CT scans of stroke patients

Brainomix at European Congress of Radiology 2016

Brainomix is attending this year’s ECR 2016 - European Congress of Radiology in Vienna

Brainomix at ANIM 2016

Brainomix will be attending the 33rd Annual Meeting of the German Stroke Society

Patient selection webinar now online

Our patient selection webinar is now available to view online!

Brainomix announces a new release for its e-ASPECTS software (v4.8)

Oxford - December 7, 2015 - Brainomix announces a new release for

UK Stroke Forum 2015

Oxford, Tuesday 1 December 2015 - Brainomix is attending this year’s UK Stroke Forum

Brainomix presented in Barclays and BGF Entrepreneurs Index

Brainomix is among the companies presented in this year’s prestigious Barclays and

Brainomix at Medica 2015

Brainomix will be presenting at Medica 2015 (Hall 16 G25-1) in Dusseldorf

Brainomix at Innovate 2015 event

Brainomix was one of 100 companies to be selected to showcase its innovation

Brainomix shortlisted for TechCities Award

Brainomix is one of three companies shortlisted in the Oxford category of

Patient selection webinar on October 22, 2015

Brainomix shortlisted for two OBN awards

Brainomix receives funding to develop clinical decision-making software for stroke patients

Brainomix Limited, a developer of automated medical imaging software for neurological

Brain scan innovation is set to transform stroke treatments

First clinical installations of e-ASPECTS

The first clinical installations of the e-ASPECTS automated CT scan scoring software

Stroke rates soar among men and women in their 40s and 50s

Automated Quantification of Stroke Damage on Brain Computed Tomography Scans: e-ASPECTS

Brainomix launches revolutionary e-ASPECTS software designed to improve outcomes for stroke patients

Breakthrough technology automates analysis of CT brain scans to support doctors in

Brainomix speaking at OBN Lunchtime Seminar

Positive endovascular trial uses ASPECTS for patient selection

Brainomix exhibiting at SPARK 2014

Brainomix exhibiting at UKSF 2014

Brainomix exhibiting at Innovate UK 2014

Brainomix at World Stroke Congress 2014

Brainomix is exhibiting at the World Stroke Congress 2014 in Istanbul

Brainomix wins Academic Enterprise ICT Award

Brainomix secures £1.2 million investment

Brainomix wins Horizon 2020 SME Instrument grant

Brainomix Announced as Academic Enterprise Awards Finalist

New technology to improve stroke diagnosis

Brainomix to present at BioTrinity 2014

Novotel London West - 13 May 2014 15:50. Michalis Papadakis, CEO of

New office move

With the continuing expansion of the Brainomix team, the company has moved

Brainomix wins award to develop life-saving Oxford stroke software

Brainomix, a start-up from Isis Innovation the Oxford University Technology Transfer Company

Automated stroke test from Oxford to save lives and costs

The latest Oxford spin-out puts the expertise of a stroke assessment team